Polyphenol · Fact sheet

Resveratrol

Also known as Trans-resveratrol

Resveratrol has laboratory and small human metabolic studies, but human findings are inconsistent. It has not been shown to extend human lifespan or reliably reproduce the effects of calorie restriction.

Not FDA approvedLimited or unclear evidence

What is Resveratrol?

Resveratrol is a plant polyphenol studied in cell signaling and metabolic research. Food exposure and concentrated supplements are different contexts.

Benefits & claims

Healthy aging, mitochondrial function, and improved insulin sensitivity are popular claims. Findings in short studies cannot demonstrate longer life.

What the evidence supports

  • Some small trials found changes in metabolic biomarkers.
  • Conflicting controlled results and short follow-up do not establish a dependable clinical or longevity benefit.
Research areas
  • Insulin sensitivity
  • Energy metabolism
  • Aging-related pathways

Dosage & frequency

Human study context

Small human resveratrol trials have produced mixed metabolic findings. There is no approved resveratrol longevity dose.

Randomized metabolic crossover study

Eleven otherwise healthy men with obesity

Amount
150 mg/day
Frequency
Daily for 30 days
Route studied or labeled
Oral

Small metabolic study; does not establish weight loss or longer life.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Studies of defined trans-resveratrol products cannot establish equivalence for every extract or combination.

Interactions & precautions

  • The small metabolic trial does not establish interactions across all medicines or concentrated resveratrol formulations.

What is still unresolved

  • Durable clinical benefit and an effective amount or schedule remain unestablished.

Side effects & risks

  • The small trials cannot characterize uncommon adverse effects or long-term safety.
  • Different preparations and exposures make it difficult to transfer tolerability findings between studies and supplements.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Limited or unclear evidence

A small crossover study in 11 men with obesity reported favorable metabolic changes. A separate four-week trial in 24 men did not improve insulin sensitivity, its primary outcome, or body composition.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Energy: reported experiences

Negative account · personal report

Less desire and energy

A commenter described lower libido and energy on repeated occasions when using resveratrol, with improvement when they stopped.

Reported use in this account

Product
Product labeled trans-resveratrol
Amount
600–1,200 mg, as reported
Frequency
Not specified clearly
Route
Not specified clearly
Duration
Repeated trials over several years; each trial length not stated

Other exposures described: Other supplements, not specified

The product and exposure were not verified. Repeated timing does not establish causation.

Read the original account
Mixed account · personal report

More energy during a multi-supplement trial

An author described better gym energy, focus and mood over six weeks, but less sleep, while using NR alongside resveratrol, quercetin and fisetin.

Reported use in this account

Product
Resveratrol-containing multi-ingredient supplement
Amount
Not specified clearly
Frequency
Not specified clearly
Route
Not specified clearly
Duration
Six weeks

Other exposures described: Nicotinamide riboside; Quercetin; Fisetin

Several products were used together. This is not an isolated resveratrol response or evidence of longer life.

Read the original account

Approval status

Resveratrol has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.

Supplement research is not FDA drug approval

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Whether any biomarker changes improve health outcomes
  • Long-term effects and interactions
  • Why results differ across populations and preparations

Summary

Conflicting controlled results and short follow-up do not establish a dependable clinical or longevity benefit.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedResveratrol metabolic study in men with obesity

    11-person crossover experiment reporting metabolic changes.

  2. pubmedResveratrol placebo-controlled trial in men with obesity

    24-person trial without improvement in the primary insulin-sensitivity outcome.

  3. fdaFDA: what approval means for supplements

    Dietary supplements are not approved by FDA for safety and effectiveness before marketing.

How we assess sources · Suggest a correction